In this episode, Mr. Domann discusses a retail strategy for minimizing prescription abandonment for brands at many stages in the product lifecycle. We cover how pharmacies and pharmacists play integral roles in the strategy.
Thought Leader: Dick Domann, Vice President, Pharmacy Services, TrialCard Inc.
Play podcast
Thursday, February 27, 2014
Tuesday, February 18, 2014
Who are the Uninsured in America?
In this episode, Patricia Ensor discusses the characteristics and behaviors of the uninsured, how they relate to the Affordable Care Act (ACA), and what it means for Pharma.
Thought Leader: Patricia Ensor, RPh, Senior Advisor, Kantar Health
Play podcast
Thought Leader: Patricia Ensor, RPh, Senior Advisor, Kantar Health
Play podcast
Labels:
ACA,
Affordable Care Act,
dan limbach,
kantar,
kantar health,
Obamacare,
Patricia Ensor,
pharmavoice,
uninsured
Monday, December 30, 2013
Biobetters: Challenges and Opportunities
The market of biologics is growing at a nearly twice the rate of pharma as a whole. Biobetters are the next big opportunity for biopharma to benefit from this growth. This podcast will explore the regulatory and scientific considerations for the development of biobetters.
Thought Leader: Hazel Gorham, Ph.D., Director, Biosimilars Development, PRA
Play podcast
Thought Leader: Hazel Gorham, Ph.D., Director, Biosimilars Development, PRA
Play podcast
Labels:
biobetters,
biologics,
biosimilars,
dan limbach,
Hazel Gorham,
pharma,
pharmavoice,
PRA
How Working Together Effectively on a Clinical Trial is Like Doing a Successful Skydive
In this episode, Ms. Ruby discusses how clinical trials are like skydiving, what some of the key challenges are in clinical trials, solving unexpected challenges, and creating a productive and collaborative relationship between CROs and sponsors.
Thought Leader: Barbara Ruby, Project Director, SynteractHCR, Inc.
Play podcast
Thought Leader: Barbara Ruby, Project Director, SynteractHCR, Inc.
Play podcast
Labels:
Barbary Ruby,
clinical trials,
CRO,
dan limbach,
pharmavoice,
skydiving,
SynteractHCR
Risk-based monitoring (RBM): A shift in paradigm from the traditional experimental design
In this episode, Mr. Penniston and Ms. Taber talk about risk-based monitoring what it is, why it's important, what are the components, what skill sets or tools are necessary, and the challenges and opportunities related to risk-based monitoring.
Thought Leaders: Mark Penniston, Senior Vice President and General Manager, Clinical Analytics, Theorem Clinical Research and Alison Taber, Vice President of Global Data Management, Theorem Clinical Research
Thursday, November 14, 2013
Creating Great Multichannel CRM Experiences: Advice from a 28-year Pharma Expert
In this episode, Mr. Lammers talks about using a multichannel business strategy in life science companies. He defines the multichannel approach, covers the core challenges, offers his review on Pharma's adoption of multichannel, and provides advice for commercial leaders.
Thought Leader: Peter Lammers, VP, Strategy, Veeva Systems
Play podcast
Thought Leader: Peter Lammers, VP, Strategy, Veeva Systems
Play podcast
Labels:
dan limbach,
life science,
multichannel,
Peter Lammers,
pharma,
pharmavoice,
Veeva,
Veeva Systems
Building Better Medication Adherence Models to Improve Health Outcomes
In this episode, Mr. Dockery covers several issues related to patient adherence, including using Big Data to predict patient behavior and improve adherence in a patient population, as well as how to accurately measure adherence rates.
Thought Leader: Jim Dockery, Executive Director, Market Data Insights and Innovation, Adheris
Play podcast
Thought Leader: Jim Dockery, Executive Director, Market Data Insights and Innovation, Adheris
Play podcast
Labels:
adherence,
Adheris,
big data,
dan limbach,
Jim Dockery,
patient adherence,
pharma,
pharmavoice
Wednesday, November 13, 2013
Unlocking the Power of Strategic Workforce Planning
In this episode, we discuss the challenges in pharma regarding workforce management, the growing trend of strategic workforce planning, and how this phenomenon will continue to evolve over the next 5 years.
Thought Leader: Mark Lanfear, Global Practice Leader, Americas Scientific Product Group, Kelly Services, Inc.
Play podcast
Thought Leader: Mark Lanfear, Global Practice Leader, Americas Scientific Product Group, Kelly Services, Inc.
Play podcast
Monday, September 30, 2013
Change Agents + Team Coaching = Transformation from the Inside Out at Sanofi
In this episode, Craig Flanagan and DJ Mitsch talk about a major culture change at Sanofi Pharmaceuticals North America: how they designed it, implemented it, what the results were, and the future of this significant undertaking. This podcast will be of great interest to anyone at a large company who is considering or has decided to implement a powerful culture change.
Thought Leaders: Darelyn "DJ" Mitsch, President, The Pyramid Resource Group, Inc. and Craig Flanagan, VP, Business Excellence and Commercial Capabilities, sanofi-aventis
Play podcast
Thought Leaders: Darelyn "DJ" Mitsch, President, The Pyramid Resource Group, Inc. and Craig Flanagan, VP, Business Excellence and Commercial Capabilities, sanofi-aventis
Play podcast
Wednesday, August 28, 2013
Risk-Based Monitoring for Late Phase: Implementation Strategies
In this episode, Ms. Harrison discusses the past, present, and future of Risk-based Monitoring. She also covers challenges and solutions, as well as a real-life example of RBM in a clinical study.
Thought Leader: Maria Harrison, Vice President, Late Phase Services, PRA
Labels:
dan limbach,
Maria Harrison,
pharmavoice,
PRA,
RBM,
risk based monitoring
Friday, May 31, 2013
Disruptive Innovation in R&D Processes
In this episode, Dr. Davis discusses open innovation, nontraditional partnerships, collaboration, new technologies, and the future of R&D.
Thought Leader: Dr. Hugh Davis, VP and head of Biologics Clinical Pharmacology Biotechnology Center of Excellence, Janssen Research and Development
Labels:
collaboration,
innovation,
Janssen,
limbach,
partnerships,
pharmavoice,
R&D
Thursday, May 30, 2013
Immersive Learning: What You Need to Know to Build Faster, Smarter Commercial Teams
In this episode, Mr. O'Grady speaks about immersive learning, what it is, and how it is the best choice for many types of mission-critical training.
Thought Leader: Garry O'Grady, SVP and General Manager, Pharmaceutical Institute
Tuesday, April 30, 2013
Developing Robust Potency Assays for Validation
In this episode, Peter Wunderli, Ph.D., discusses PPD's recent laboratory facility expansion, outlines challenges and critical factors in cell-based bio bioassay product development, talks about disease states suitable for this type of technology, and finally, takes a look into the future of cell-based assays.
Thought Leader: Peter Wunderli, Ph.D., Associate Director, Biopharmaceutical Services at PPD
Labels:
bioassay,
cell-based assay,
limbach,
pharmavoice,
PPD,
wunderli
What is Creativity?
In this episode, Anthony Rotolo talks about creativity in the health and wellness space. We cover the importance of creativity in advertising, how to be creative, and, when used properly, how creativity influences behavior change.
Thought Leader: Anthony Rotolo, Chief Creative Officer, TRUE Health + Wellness
Monday, April 22, 2013
Value of a Credential in the Medical Publications Profession
In this episode, Stacy Simpson Logan talks about the value of obtaining a CMPP credential for employees and employers as well as the future of the CMPP program. CMPP stands for Certified Medical Publication Professional and is administered by ISMPP, the International Society for Medication Publication Professionals.
Thought Leader: Stacy Simpson Logan, Chair, CMPP Board of Trustees President, Waterfall Consulting
Friday, March 29, 2013
What Do Mick Jagger, Diabetes, Heart Disease, and Cancer Have in Common?
In this episode, Ms. Hammond talks about our aging society and how the industry needs to address its therapies to reflect the differences in age groups, including the old, and the very old.
Date Posted: 03/28/2013 Size: 9.6MB Length: 00:20:52
Thought Leader: Melissa Hammond MSN, GNP, Managing Director, Snowfish
Labels:
aging,
cancer,
dan limbach,
diabetes,
heart disease,
melissa hammond,
mick jagger,
pharmavoice,
snowfish
Transitioning Clinical Trial Patients to Commercial Supply via Managed Access Programs
This podcast describes how Managed Access Programs can continue treatment access for patients coming out of registration or other clinical trials who need to transition to commercial supply.
Thought Leaders: Suzanne Gagnon, MD, Chief Medical Officer, Idis, Karen Searle PhD, Study Director, Neuroscience & General Medicine (NGM), Eisai Global Clinical Development and Michelle Gee, PhD, Director, Neuroscience & General Medicine (NGM), Eisai Global Clinical Development
Play podcast
Thought Leaders: Suzanne Gagnon, MD, Chief Medical Officer, Idis, Karen Searle PhD, Study Director, Neuroscience & General Medicine (NGM), Eisai Global Clinical Development and Michelle Gee, PhD, Director, Neuroscience & General Medicine (NGM), Eisai Global Clinical Development
Play podcast
Thursday, January 31, 2013
Conducting User Testing to Improve Clinical Trial Technologies
Thought Leader: Joseph Bedford, Ph.D., Director of Marketing, Almac Clinical Technologies
In this episode, we discuss how user testing research improves the clinical trial process for patients, sites, and sponsors.
For more information about Almac Clinical Technologies, visit www.almacgroup.com.
Play Podcast.
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
In this episode, we discuss how user testing research improves the clinical trial process for patients, sites, and sponsors.
For more information about Almac Clinical Technologies, visit www.almacgroup.com.
Play Podcast.
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Thursday, December 27, 2012
Demystifying Routine Care Coverage in Trial Budgeting
Thought Leaders: Jessica Dolfi, MS, Senior Business Consultant, Medidata Solutions Worldwide and Kelly Willenberg, MBA, BSN, CHRC, CHC, Kelly Willenberg, LLC
In this episode, we discuss standard of care in clinical trials, challenges for sites and sponsors, and how standard of care issues affect day-to-day work in trials.
For more information about Medidata Solutions Worldwide, visit www.mdsol.com.
Play Podcast.
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Labels:
clinical trials,
healthcare,
medidata,
podcast,
standard of care
Friday, November 16, 2012
Women's Health Issues in Clinical Research: Key Post-approval Challenges
Thought Leaders: Jessica Albano, PhD, MPH, Senior Director, Epidemiology, Post Approval & Strategic Services, and Dr. Vikki Brown, Medical Director for the Post-Approval and Strategic Services division of INC Research, Inc.
In this episode, our experts discuss the primary challenges regarding women's health in clinical research. They also cover pregnancy registries and lactation studies, as well as available regulatory guidance related to this type of research.
For more information about INC Research, visit www.incresearch.com.
Play Podcast.
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Thursday, November 15, 2012
Informed Targeting to Healthcare Professionals
Thought Leader: R.J. Lewis, President & CEO, eHealthcare Solutions
In this episode, Mr. Lewis discusses how pharma can better connect with HCP audiences using authentication, list matching, and other techniques. He also covers how effective communications can impact prescription writing, and how to overcome hurdles from Medical, Legal, and Regulatory (MLR) departments.
For more information about eHealthcare Solutions, visit www.ehealthcaresolutions.com.
Play Podcast.
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Labels:
authentication,
eHealthcare,
HCP,
legal,
medical,
podcast,
regulatory
Friday, October 05, 2012
Untangling Alzheimer's Disease
Thought Leader: Prof. Claude Wischik, M.D., Ph.D., TauRx Therapeutics
In this episode, Professor Wischik describes his ongoing journey of research and development for Alzheimer's Disease. This intriguing podcast covers the man, the molecule, and the market.
For more information about TauRx Therapeutics, visit www.taurx.com.
Play Podcast.
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Labels:
alzheimers,
alzheimers disease,
drug development,
podcast
Thursday, October 04, 2012
How to Tap the Pharmacy for Clinical Trial Patients
Thought Leaders: Steve Hoffman, RPh, Chief Pharmacy Officer, McKesson Patient Relationship Solutions, Lynda Stout, PharmD, Lombard Health Mart Pharmacy
In this episode, our experts discuss pharmacy-based patient recruitment programs for clinical trials.
For more information about McKesson, visit www.mckesson.com.
Play Podcast.
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Tuesday, October 02, 2012
What are ACOs and Why Should You Care?
Thought Leader: Anthony D. Slonim, MD, DrPH, Executive Vice President and Chief Medical Officer, Barnabas Health. Sponsored: by CMR Institute
In this episode, Dr. Slonim discusses ACOs, how they offer a new model for health care, how they create opportunities for biopharmaceutical companies, and how a shift to ACOs would affect all facets of the health care continuum.
For more information about CMR Institute, visit www.cmrinstitute.org.
Play Podcast.
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Friday, September 28, 2012
Successful Email Marketing Methods: How to Boost Response by 400% or More
Thought Leader: Terry Nugent, Executive Vice President, Sales and Marketing, MMS, Inc.
In this episode, Mr. Nugent discusses the challenges of using email in pharmaceutical marketing, as well as some best practices for achieving the highest possible ROI.
For more information about MMS, visit www.mmslists.com.
Play Podcast.
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Labels:
email marketing,
MMS,
pharma marketing,
pharmaceutical marketing,
podcast,
ROI
Friday, August 31, 2012
Reaching Healthcare Providers While Remaining Compliant
Thought Leader: Erez Lapsker, CEO, MediScripts
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Labels:
hcp marketing,
mediscripts,
pharmavoice,
podcast,
prescription pads
Global Biosimilar Development
Thought Leader: Rodeina Challand, Executive Director, Biosimilars Development, PRA International
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Labels:
biosimilars,
drug development,
pharmavoice,
PRA,
PRA INternational
Future of Pharmacovigilance: Five Imperatives that will Drive Improved Business
Thought Leaders: Nagaraja Srivatsan, SVP, Head of Life Sciences, North America at Cognizant Venkat Venkataramanan, Director, Pharmacovigilance Domain Head, Cognizant, George Botsakos, Senior Director and Life Sciences R&D Leader in Cognizant's Business Consulting group
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Monday, July 09, 2012
Improve Adherence with Patient and Caregiver Support Programs
Thought Leader: Lou Shapiro, Senior VP, Business Development, Tunstall AMAC Life Sciences
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Tuesday, June 12, 2012
Influencing the Real Decision Makers: 7 Lenses For Marketing Health to Women
Thought Leaders: Chris DeAngelis, VP, Sales, SSI and Jonathan Kay, Head of Healthcare, Penn Schoen Berland
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Labels:
behaviors,
caregivers,
health,
penn schoen berland,
SSI,
women
Friday, June 08, 2012
Understanding Patients in the Emerging Market of Russia
Thought Leader: Gina Isherwood, Ph.D., Regional Brand Director, Kantar Health
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Wednesday, May 02, 2012
Top Ten Patient Enrollment and Retention Myths
In this episode, Mr. Connor shares 4 of his top 10 myths about patient enrollment and retention, and we'll tell you where to get the entire list.
For more information about Acurian, visit www.acurian.com.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Thursday, April 12, 2012
Patient Access to Investigational Drugs: Removing Barriers
Thought Leader: Simon Estcourt, Senior VP, Strategy and Corporate Development, Idis
In this episode, Mr. Estcourt shares his perspective on programs that enable patient access to medicines outside the clinical trial or commercial setting and the barriers that remain despite well-defined regulations governing such access.
Play Podcast
In this episode, Mr. Estcourt shares his perspective on programs that enable patient access to medicines outside the clinical trial or commercial setting and the barriers that remain despite well-defined regulations governing such access.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Tuesday, April 03, 2012
Insights from the Field: Tele-Sales Builds Relationships between Brand and HCPs
Thought Leader: Lou Shapiro, Senior VP, Business Development, PhoneScreen, an AMAC company
In this episode, Mr. Shapiro describes his experiences working with companies on successful tele-detailing and tele-sales programs, including numerous insights on the unforeseen benefits of these solutions.
Play Podcast
In this episode, Mr. Shapiro describes his experiences working with companies on successful tele-detailing and tele-sales programs, including numerous insights on the unforeseen benefits of these solutions.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Wednesday, March 28, 2012
DIA 2012 48th Annual Meeting Preview
Thought Leader: Craig Lipset, DIA Conference Chair, Head of Clinical Innovation, Development Operations within Worldwide Research & Development, Pfizer
In this episode of the PharmaVOICE Executive Suite Podcast Series, Mr. Lipset shares his thoughts on being Chairman of the DIA 2012 48th Annual Meeting in June, and how his work at Pfizer helps him in his role with DIA including this year's theme on collaboration. He also comments on how industry trends will impact drug development and clinical trials, and offers a couple tips on getting the most out of this year's DIA Annual Meeting in Philadelphia.
Play Podcast
In this episode of the PharmaVOICE Executive Suite Podcast Series, Mr. Lipset shares his thoughts on being Chairman of the DIA 2012 48th Annual Meeting in June, and how his work at Pfizer helps him in his role with DIA including this year's theme on collaboration. He also comments on how industry trends will impact drug development and clinical trials, and offers a couple tips on getting the most out of this year's DIA Annual Meeting in Philadelphia.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Thursday, February 02, 2012
Understanding the Impact of Drug Induced Liver Injury on Drug Development
Thought Leader: Steve Lobel, PhD, D-ABMLI, MBA, FACB, Vice-president Global Laboratory Operations, PPD
In this episode, Dr. Lobel talks about Drug-induced liver injury, also known as DILI. We'll cover what DILI is, how it is identified, and its effects on the clinical development process. At the end of this podcast, you'll learn where you can download a related white paper on this topic.
Play Podcast
In this episode, Dr. Lobel talks about Drug-induced liver injury, also known as DILI. We'll cover what DILI is, how it is identified, and its effects on the clinical development process. At the end of this podcast, you'll learn where you can download a related white paper on this topic.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
The Evolving Social Media Lifecycle in Pharma
Thought Leaders: Nagaraja Srivatsan, Dileep Srinivasan, and Alexander Gochtovtt, Cognizant
In this episode, a trio of experts from Cognizant talk about numerous issues involving social media in the life sciences. There is also a related white paper you may download.
Play Podcast
In this episode, a trio of experts from Cognizant talk about numerous issues involving social media in the life sciences. There is also a related white paper you may download.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
How the New Role of the CRO Affects Patient Enrollment
Thought Leader: Richard Malcolm, CEO, Acurian
In this episode, Dr. Malcolm discusses how the role of the CRO is transitioning from commodity service supplier to strategic partner, and the unintended negative consequences this could have on what is already the most expensive part of clinical trials: patient enrollment.
Play Podcast
In this episode, Dr. Malcolm discusses how the role of the CRO is transitioning from commodity service supplier to strategic partner, and the unintended negative consequences this could have on what is already the most expensive part of clinical trials: patient enrollment.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Wednesday, February 01, 2012
Transformative Leadership
Thought Leader: Dr. Deborah Dunsire, President and CEO, Millennium: The Takeda Oncology Company
In this episode, Dr. Dunsire shares her insights on the quest to find a cure for cancer, on women striving for positions in the C-Suite, and thoughts on her own career development and recognition as the 2009 HBA Woman of the Year.
Play Podcast
In this episode, Dr. Dunsire shares her insights on the quest to find a cure for cancer, on women striving for positions in the C-Suite, and thoughts on her own career development and recognition as the 2009 HBA Woman of the Year.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Wednesday, January 04, 2012
Automating Pharma FCPA Due Diligence
Thought Leader: Robert Shecterle, Vice President of Marketing, Aravo
In this episode, Mr. Shecterle discusses FCPA Compliance and anti-bribery practices at large pharmaceutical and life sciences companies.
Play Podcast
In this episode, Mr. Shecterle discusses FCPA Compliance and anti-bribery practices at large pharmaceutical and life sciences companies.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
The C-Suite: How Biotech Improves the Standard of Care of Patients
Thought Leader: Brad Thompson, Ph.D., Chairman, President and CEO, Oncolytics Biotech
In this episode, Dr. Thompson talks about how biotech is making improvements in the standard of care, and the impact of Pharma 3.0. He also talks about his own experience taking REOLYSIN® through the drug development process, the genesis of Oncolytics Biotech, and shares some insights for biotech entrepreneurs.
Play Podcast
In this episode, Dr. Thompson talks about how biotech is making improvements in the standard of care, and the impact of Pharma 3.0. He also talks about his own experience taking REOLYSIN® through the drug development process, the genesis of Oncolytics Biotech, and shares some insights for biotech entrepreneurs.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Understanding How Social Networks Drive Healthcare Decisions: Mapping a New "Influence" Landscape
Thought Leader: Chris DeAngelis, Vice President, Strategic Initiatives, SSI
In this episode, Mr. DeAngelis discusses a variety of issues regarding consumers' usage of social media for healthcare information. You'll learn some of the results of a study of over 1,400 U.S. consumers participating in proprietary panels and web communities.
Play Podcast
In this episode, Mr. DeAngelis discusses a variety of issues regarding consumers' usage of social media for healthcare information. You'll learn some of the results of a study of over 1,400 U.S. consumers participating in proprietary panels and web communities.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Tele-detailing: Responding to Changing Pharma Sales Models
Thought Leader: Lou Shapiro, Senior Vice President, AMAC Services Group and the PhoneScreen brand
In this episode, Mr. Shapiro talks about the challenges life science companies face when providing information on their products to physicians and healthcare providers.
Play Podcast
In this episode, Mr. Shapiro talks about the challenges life science companies face when providing information on their products to physicians and healthcare providers.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Tuesday, January 03, 2012
Additive Patient Recruitment
Thought Leader: Roger Smith, Senior Vice President, Operations, Acurian
In this episode, Mr. Smith talks about clinical trial enrollment and the concept of Additive Patient Recruitment.
Play Podcast
In this episode, Mr. Smith talks about clinical trial enrollment and the concept of Additive Patient Recruitment.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Wednesday, November 16, 2011
Understanding Patients in the Emerging Market of Brazil
Date Posted: 11/10/2011
Size: 6.89MB
Length: 00:15:03
Thought Leader: David Pomerantz, Senior Vice President, Business Development, Kantar Health
In this episode, Mr. Pomerantz talks about the influence of patients in pharma and especially in emerging markets such as Brazil.
Play Podcast
Size: 6.89MB
Length: 00:15:03
Thought Leader: David Pomerantz, Senior Vice President, Business Development, Kantar Health
In this episode, Mr. Pomerantz talks about the influence of patients in pharma and especially in emerging markets such as Brazil.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Planning for Clinical Trial Conduct in Emerging Locations
Date Posted: 9/28/2011
Size: 6.4MB
Length: 00:14:07
Thought Leader: Kelly Larrabee, RN, MBA, MS, Senior Director, Clinical Services, ClearTrial
In this episode Ms. Larrabee discusses clinical trials in emerging countries, and the major planning challenges, plus how collaborative partnerships are helping in the search for new treatments. For more information about ClearTrial, visit http://www.cleartrial.com/.
Play Podcast
Size: 6.4MB
Length: 00:14:07
Thought Leader: Kelly Larrabee, RN, MBA, MS, Senior Director, Clinical Services, ClearTrial
In this episode Ms. Larrabee discusses clinical trials in emerging countries, and the major planning challenges, plus how collaborative partnerships are helping in the search for new treatments. For more information about ClearTrial, visit http://www.cleartrial.com/.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Labels:
clinical,
emerging,
global clinical trials,
markets
Keys to Partnering with a Pharmaceutical Call Center
Date Posted: 9/13/2011
Size: 4.67MB
Length: 00:10:13
Thought Leader: Lou Shapiro, Senior Vice President, AMAC Services Group and the PhoneScreen brand
In this episode, Mr. Shapiro shares his views on how pharmaceutical, biotech, and medical device companies can benefit from partnering with a qualified pharmaceutical call center. For more information about PhoneScreen, visit http://www.phonescreen.com/.
Play Podcast
Size: 4.67MB
Length: 00:10:13
Thought Leader: Lou Shapiro, Senior Vice President, AMAC Services Group and the PhoneScreen brand
In this episode, Mr. Shapiro shares his views on how pharmaceutical, biotech, and medical device companies can benefit from partnering with a qualified pharmaceutical call center. For more information about PhoneScreen, visit http://www.phonescreen.com/.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Leveraging Customer Insights to Maximize ROI
Date Posted: 8/31/2011
Size: 6.17MB
Length: 00:13:29
Thought Leaders: Jay Bolling, President & CEO, Chuck McLeester, SVP Planning, Metrics & Analytics, Kurt Mueller, Chief Digital & Science Officer, Roska Healthcare Advertising
In this episode, the team at Roska Healthcare discusses new ways to use behavioral and attitudinal data to enhance customer targeting and messaging. They review a unique, new communications model (Catalyst-tm) that increases customer 'acceptance' (engagement) and drives more people to take action.
Play Podcast
Size: 6.17MB
Length: 00:13:29
Thought Leaders: Jay Bolling, President & CEO, Chuck McLeester, SVP Planning, Metrics & Analytics, Kurt Mueller, Chief Digital & Science Officer, Roska Healthcare Advertising
In this episode, the team at Roska Healthcare discusses new ways to use behavioral and attitudinal data to enhance customer targeting and messaging. They review a unique, new communications model (Catalyst-tm) that increases customer 'acceptance' (engagement) and drives more people to take action.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Mentoring: A Professional Advantage
Date Posted: 8/12/2011
Size: 6.17MB
Length: 00:13:29
Thought Leader: Laurie Cooke, CEO, Healthcare Businesswomen's Association
In this episode, Ms. Cooke discusses what it means to be honored as Mentor of the Year, why mentoring is an important career development strategy, and the HBA's commitment to helping its members develop their careers through mentoring and coaching.
Play Podcast
Size: 6.17MB
Length: 00:13:29
Thought Leader: Laurie Cooke, CEO, Healthcare Businesswomen's Association
In this episode, Ms. Cooke discusses what it means to be honored as Mentor of the Year, why mentoring is an important career development strategy, and the HBA's commitment to helping its members develop their careers through mentoring and coaching.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Understanding the Power of KOL Influence Mapping
Date Posted: 6/27/2011
Size: 6.37MB
Length: 00:13:55
Thought Leader: Gary Bartolacci, Senior Account Director, Kantar Health
In this episode, Mr. Bartolacci discusses the power of key opinion leaders nationally, regionally, and locally. He explains how pharmaceutical companies can achieve stronger results using influence mapping, various approaches to influence mapping (including the benefits and risks of these studies) and best practices, along with addressing clients' most common questions.
Play Podcast
Size: 6.37MB
Length: 00:13:55
Thought Leader: Gary Bartolacci, Senior Account Director, Kantar Health
In this episode, Mr. Bartolacci discusses the power of key opinion leaders nationally, regionally, and locally. He explains how pharmaceutical companies can achieve stronger results using influence mapping, various approaches to influence mapping (including the benefits and risks of these studies) and best practices, along with addressing clients' most common questions.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Clinical Supply Optimization: Challenges & Solutions
Date Posted: 5/31/2011
Size: 7.8MB
Length: 00:17:03
Thought Leader: Steven Yoder, Director, Client Services, Fisher Clinical Services
In this episode, Mr. Yoder discusses the challenges and benefits of clinical supply optimization and what the future looks like as companies strive to achieve a balance between optimization and cost-reduction.
Play Podcast
Size: 7.8MB
Length: 00:17:03
Thought Leader: Steven Yoder, Director, Client Services, Fisher Clinical Services
In this episode, Mr. Yoder discusses the challenges and benefits of clinical supply optimization and what the future looks like as companies strive to achieve a balance between optimization and cost-reduction.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Labels:
global clinical trials,
optimization,
solutions,
supply
Networked Drug Development - Bringing Assets, Capital and Services Together
Date Posted: 5/31/2011
Size: 5.56MB
Length: 00:12:09
Thought Leader: Tim Dietlin, VP of Alliance Development, INC Research
In this episode, Mr. Dietlin discusses a burgeoning concept called the Networked Drug Development Alliance, what it is, what's driving it, and how they improve the process for pharmaceutical companies and investors.
Play Podcast
Size: 5.56MB
Length: 00:12:09
Thought Leader: Tim Dietlin, VP of Alliance Development, INC Research
In this episode, Mr. Dietlin discusses a burgeoning concept called the Networked Drug Development Alliance, what it is, what's driving it, and how they improve the process for pharmaceutical companies and investors.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Improving Safety, Security, and Speed using Voice Biometrics
Date Posted: 4/29/2011
Size: 7.95MB
Length: 00:17:23
Thought Leader: Richard Scarbath , Director, Enterprise Accounts, Angel
In this episode, Mr. Scarbath discusses the movement into voice biometrics for voice signatures and authentication. He provides a general overview of the technology and how it is being applied in the pharmaceutical industry and sampling world..
Play Podcast
Size: 7.95MB
Length: 00:17:23
Thought Leader: Richard Scarbath , Director, Enterprise Accounts, Angel
In this episode, Mr. Scarbath discusses the movement into voice biometrics for voice signatures and authentication. He provides a general overview of the technology and how it is being applied in the pharmaceutical industry and sampling world..
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Labels:
iometrics,
safety,
security,
speed,
voice biometrics
The Undercalculated Costs Driving Today's Clinical Trials
Date Posted: 4/29/2011
Size: 12.0MB
Length: 00:26:17
Thought Leader: Ian Hunter, Global Account Director, Fisher Clinical Services
In this episode, Mr. Hunter, discusses the many variables and issues surrounding transportation and distribution of product for global clinical trials.
Play Podcast
Size: 12.0MB
Length: 00:26:17
Thought Leader: Ian Hunter, Global Account Director, Fisher Clinical Services
In this episode, Mr. Hunter, discusses the many variables and issues surrounding transportation and distribution of product for global clinical trials.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Thursday, April 07, 2011
Oncology Trials: A Novel Approach to Patient Accrual
Date Posted: 3/30/2011
Size: 5.95MB
Length: 00:13:02
Thought Leader: Ed Watson, Director of Oncology, Acurian, Inc.
In this episode, Ed Watson discusses some of the challenges associated with recruiting for clinical studies in oncology, the roles of various key stakeholders, and the sponsor community's response to a new approach to patient accrual.
Size: 5.95MB
Length: 00:13:02
Thought Leader: Ed Watson, Director of Oncology, Acurian, Inc.
In this episode, Ed Watson discusses some of the challenges associated with recruiting for clinical studies in oncology, the roles of various key stakeholders, and the sponsor community's response to a new approach to patient accrual.
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Streamlining Clinical Trials with an Approved Phrase Library for Labeling
Date Posted: 3/24/2011
Size: 7.68MB
Length: 00:16:32Thought Leader: Kevin Shea, Label Program Director, Clintrak Clinical Labeling Services LLC., a part of Thermo Fisher Scientific
In this episode, Mr. Shea discusses how clinical trials are affected by label text issues, streamlining the process with a phrase library, and the advantages of managing a phrase library with a dedicated system.
Size: 7.68MB
Length: 00:16:32Thought Leader: Kevin Shea, Label Program Director, Clintrak Clinical Labeling Services LLC., a part of Thermo Fisher Scientific
In this episode, Mr. Shea discusses how clinical trials are affected by label text issues, streamlining the process with a phrase library, and the advantages of managing a phrase library with a dedicated system.
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Why ISMPP?: Leadership, Value, and Best Practices for Medical Publication Professionals
Date Posted: 3/4/2011
Size: 6.78MB
Length: 00:14:49
Thought Leaders: Kim Goldin, Executive Director, Julia Ralston, President, and Robert Norris, Past President, ISMPP
In this episode, our thought leaders discuss what ISMPP is and how it's evolved, how the organization can help Medical Publication Professionals, and the 2011 annual meetings in the US in April and in Europe in November.
Size: 6.78MB
Length: 00:14:49
Thought Leaders: Kim Goldin, Executive Director, Julia Ralston, President, and Robert Norris, Past President, ISMPP
In this episode, our thought leaders discuss what ISMPP is and how it's evolved, how the organization can help Medical Publication Professionals, and the 2011 annual meetings in the US in April and in Europe in November.
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Building a Communications Bridge: A Best Practice for Conducting Clinical Trials in India
Date Posted: 3/1/2011
Size: 7.4MB
Length: 00:16:10
Thought Leaders: Dr. James A. Bannon, Executive Chairman and Dr. Edward J. Brennan, Jr. President and CEO, IndiPharm
In this episode, Dr. Bannon and Dr. Brennan discuss conducting clinical trials in India. They cover why a seamless communication strategy is important, how an in-country partner can improve the trial outcome, regulatory issues in India, and the ROI of conducting clinical trials in India.
Size: 7.4MB
Length: 00:16:10
Thought Leaders: Dr. James A. Bannon, Executive Chairman and Dr. Edward J. Brennan, Jr. President and CEO, IndiPharm
In this episode, Dr. Bannon and Dr. Brennan discuss conducting clinical trials in India. They cover why a seamless communication strategy is important, how an in-country partner can improve the trial outcome, regulatory issues in India, and the ROI of conducting clinical trials in India.
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
A New Wellness-Centric Ecosystem
Date Posted: 1/31/2011
Size: 4.63MB
Length: 00:10:07
Thought Leaders: Nagaraja Srivatsan, Senior VP and Head of Life Sciences, North America and Dr. Elby Nash, Principal, Cognizant Business Consulting, Life Sciences, Cognizant
In this episode, Srivatsan and Dr. Nash discuss a forward-thinking business model that focuses on overall patient wellness and preventative medicine rather than simply treating illness.
Size: 4.63MB
Length: 00:10:07
Thought Leaders: Nagaraja Srivatsan, Senior VP and Head of Life Sciences, North America and Dr. Elby Nash, Principal, Cognizant Business Consulting, Life Sciences, Cognizant
In this episode, Srivatsan and Dr. Nash discuss a forward-thinking business model that focuses on overall patient wellness and preventative medicine rather than simply treating illness.
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Best Practices for Your CRO Partnerships
Date Posted: 1/31/2011
Size: 8.04MB
Length: 00:17:34
Thought Leader: Colin Terry, Executive Vice President, Commercial Operations, Aptuit
In this episode, Mr. Terry shares his perspective on how drug developers can move beyond the typical, transactional, approach to outsourcing and instead, create true partnerships with their CROs that reflect a commitment to a shared development vision.
Size: 8.04MB
Length: 00:17:34
Thought Leader: Colin Terry, Executive Vice President, Commercial Operations, Aptuit
In this episode, Mr. Terry shares his perspective on how drug developers can move beyond the typical, transactional, approach to outsourcing and instead, create true partnerships with their CROs that reflect a commitment to a shared development vision.
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
How Integrated Solutions Can Optimize Clinical Research
Date Posted: 1/31/2011
Size: 5.97MB
Length: 00:13:03
Thought Leader: James DeSanti, CEO, PharmaVigilant
In this episode, Mr. DeSanti discusses Integrated Solutions in clinical research. We define the concept, outline how sponsors can utilize it, and finally, we cover the benefits and ROI of an integrated approach.
Size: 5.97MB
Length: 00:13:03
Thought Leader: James DeSanti, CEO, PharmaVigilant
In this episode, Mr. DeSanti discusses Integrated Solutions in clinical research. We define the concept, outline how sponsors can utilize it, and finally, we cover the benefits and ROI of an integrated approach.
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Unveiling the Potential of the CEE Market
Date Posted: 1/31/2011
Size: 8.78MB
Length: 00:19:11
Thought Leader: Pali F. Kollath DVM, MBA Regional Director, Central & Eastern Europe and Treatment Value Practice, Kantar Health
In this episode, Pali F. Kollath discusses Central and Eastern Europe as an emerging market for pharmaceutical companies. You'll learn how large this market is, the benefits of moving into this market, some of the risks and challenges, best practices for setting up operations, and where the market is heading in the future.
Size: 8.78MB
Length: 00:19:11
Thought Leader: Pali F. Kollath DVM, MBA Regional Director, Central & Eastern Europe and Treatment Value Practice, Kantar Health
In this episode, Pali F. Kollath discusses Central and Eastern Europe as an emerging market for pharmaceutical companies. You'll learn how large this market is, the benefits of moving into this market, some of the risks and challenges, best practices for setting up operations, and where the market is heading in the future.
Download transcript and white paper
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Tuesday, January 04, 2011
China: An Emerging Market for Cancer Therapeutics
Date Posted: 12/30/2010
Size: 6.12MB
Length: 00:13:48
Thought Leader: Richard Wagner, Ph.D., Senior Director, Kantar Health
In this episode, Dr. Wagner talks about China as an emerging market for cancer drugs, including the differences between the U.S. and China in terms of access to testing and drugs, as well as differences in healthcare coverage. We'll also discuss some of Kantar's latest research on cancer in China.
Size: 6.12MB
Length: 00:13:48
Thought Leader: Richard Wagner, Ph.D., Senior Director, Kantar Health
In this episode, Dr. Wagner talks about China as an emerging market for cancer drugs, including the differences between the U.S. and China in terms of access to testing and drugs, as well as differences in healthcare coverage. We'll also discuss some of Kantar's latest research on cancer in China.
Download transcript and white paper
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Monday, December 27, 2010
Improving Clinical Research ROI using Remote Source Document Verification
Date Posted: 12/17/2010
Size: 4.92MB
Length: 00:10:45
Thought Leader: James DeSanti, CEO, PharmaVigilant
In this episode, Mr. DeSanti discusses remote source document verification, also known as rSDV. First we'll define rSDV, and then talk about the benefits, challenges, and the ROI of implementing rSDV, as well as other issues.
Size: 4.92MB
Length: 00:10:45
Thought Leader: James DeSanti, CEO, PharmaVigilant
In this episode, Mr. DeSanti discusses remote source document verification, also known as rSDV. First we'll define rSDV, and then talk about the benefits, challenges, and the ROI of implementing rSDV, as well as other issues.
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Tuesday, November 02, 2010
Streamlining Clinical Research with Electronic Trial Master Files
Date Posted: 9/30/2010
Size: 7.93MB
Length: 00:17:19
Thought Leader: James DeSanti, CEO, PharmaVigilant
In this episode, Mr. DeSanti discusses the clinical trials trend of moving to an Electronic Trial Master File platform. He covers the strategic and practical aspects of making the move, and what the payback is for doing so.
Size: 7.93MB
Length: 00:17:19
Thought Leader: James DeSanti, CEO, PharmaVigilant
In this episode, Mr. DeSanti discusses the clinical trials trend of moving to an Electronic Trial Master File platform. He covers the strategic and practical aspects of making the move, and what the payback is for doing so.
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
An Integrated Approach to Comparator Sourcing and Supply Chain Management Solutions
Date Posted: 9/30/2010
Size: 7.93MB
Length: 00:17:19
Thought Leader: Dr. Philippe Muller, Managing Director Manufacturing and Comparator Services, Fisher Clinical Services
Size: 7.93MB
Length: 00:17:19
Thought Leader: Dr. Philippe Muller, Managing Director Manufacturing and Comparator Services, Fisher Clinical Services
In this episode, we'll discuss using comparator drugs in clinical trials, and overcoming the issues and challenges of using comparators.
Download related whitepaper
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Moving Medical Affairs to the Cloud Proves to be a Very Down-to-Earth Strategy for AstraZeneca
Date Posted: 9/24/2010
Size: 6.22MB
Length: 00:13:35
Thought Leaders: John Pelkowski, Senior Director of Client Engagement for Medical Affairs, AstraZeneca and Kevin Krause, Senior Director of Medical Affairs, Strategy & Operations, AstraZeneca
Size: 6.22MB
Length: 00:13:35
Thought Leaders: John Pelkowski, Senior Director of Client Engagement for Medical Affairs, AstraZeneca and Kevin Krause, Senior Director of Medical Affairs, Strategy & Operations, AstraZeneca
In this episode, we'll discuss AstraZeneca's recent move to the cloud. The company switched from an on-premise, custom-developed CRM system to Veeva Systems' multi-tenant SaaS CRM system.
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Monday, November 01, 2010
Best Practices for Sites and CRO Collaboration
Date Posted: 07/29/2010
Size: 6.64MB
Length: 00:14:31
Thought Leaders: Ed Jahn, Clinical Operations Specialist, Criterium and Jaime Campbell Hudak, Clinical Data Liaison II, Criterium
Size: 6.64MB
Length: 00:14:31
Thought Leaders: Ed Jahn, Clinical Operations Specialist, Criterium and Jaime Campbell Hudak, Clinical Data Liaison II, Criterium
In this episode, our thought leaders discuss ways for CROs and sites to work together to achieve the best possible results. This episode is chock full of best practices and tips, as well as an overview of the results of a July 2010 survey of sites.
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Thursday, June 03, 2010
The Global Strategic Partner Model as a Key Enabler in Clinical Transformation
Date Posted: 6/1/2010
Size: 5.5MB
Length: 00:11:59
Thought Leaders: Nagaraja Srivatsan, Vice President, Head of Life Sciences, North America, Cognizant, Ramana Reddy, Practice Leader Life Sciences, Cognizant Business Consulting, Krishnan Rajagopalan Ph.D., Global Head of Life Sciences BPO, Cognizant
Size: 5.5MB
Length: 00:11:59
Thought Leaders: Nagaraja Srivatsan, Vice President, Head of Life Sciences, North America, Cognizant, Ramana Reddy, Practice Leader Life Sciences, Cognizant Business Consulting, Krishnan Rajagopalan Ph.D., Global Head of Life Sciences BPO, Cognizant
In this episode, we'll discuss the current state of R&D in the pharmaceutical industry, the ongoing transformation of clinical operations and how the global strategic partner model is facilitating many of these changes.
Download Whitepaper
Download Transcript
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Understanding Cloud Computing for CRM
Date Posted: 6/1/2010
Size: 6.47MB
Length: 00:14:09
Thought Leader: Matt Wallach, Executive VP and General Manager, Veeva Systems
Size: 6.47MB
Length: 00:14:09
Thought Leader: Matt Wallach, Executive VP and General Manager, Veeva Systems
In this episode, Mr. Wallach discusses how pharmaceutical companies can benefit from Software as a Service and Cloud Computing to improve the sales process within the life-sciences industry.
Download Transcript
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Wednesday, May 26, 2010
U.S. and Global Information Security Standards in Patient Recruitment
Date Posted: 05/17/2010
Size: 4.1MB
Length: 00:8:58
Thought Leader: Roger Smith, Senior VP, Operations, Acurian Inc.
Size: 4.1MB
Length: 00:8:58
Thought Leader: Roger Smith, Senior VP, Operations, Acurian Inc.
In this episode, Mr. Smith provides detailed information related to security standards in patient recruitment, what clinical teams need to consider when selecting the right recruitment partner, and how to navigate and understand the complex guidelines and regulations in this space.
Download Whitepaper
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Clinical Delivery Alliances in Drug Development
Date Posted: 05/11/2010
Size: 6.88MB
Length: 00:15:02
Thought Leader: Tim Dietlin, VP of Alliance Development, INC Research
Size: 6.88MB
Length: 00:15:02
Thought Leader: Tim Dietlin, VP of Alliance Development, INC Research
In this episode Mr. Dietlin talks about Clinical Delivery Alliances; what they are and how they can benefit the drug development process.
Download Whitepaper
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Industry Experts Weigh in on Marketing Research after PMRG
Date Posted: 05/1/2010
Size: 10.9MB
Length: 00:23:55
Thought Leaders: Debbie Kossman, Senior VP, National Analysts Worldwide, and the 2010 President of PMRG, Juliana Mastroserio, Director or Marketing Research, Johnson & Johnson, Lynnette Cooke, CEO, Kantar Health
Size: 10.9MB
Length: 00:23:55
Thought Leaders: Debbie Kossman, Senior VP, National Analysts Worldwide, and the 2010 President of PMRG, Juliana Mastroserio, Director or Marketing Research, Johnson & Johnson, Lynnette Cooke, CEO, Kantar Health
In this episode we'll cover various topics pertaining to marketing research in the pharmaceutical industry. We have three distinguished thought leaders who represent different perspectives on marketing research, and offer some takeways from the 2010 PMRG Annual Conference.
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Thursday, April 08, 2010
Leveraging Expanded Access and Named-Patient Programs: Best Practices for Small and Emerging Biotech and Pharma Companies
Date Posted: 03/31/2010
Size: 6.64MB
Length: 00:14:32
Thought Leader: Nicky Wisener, Biopharmaceutical Account Manager, Idis
Size: 6.64MB
Length: 00:14:32
Thought Leader: Nicky Wisener, Biopharmaceutical Account Manager, Idis
In this episode, Ms. Wisener describes how expanded access and named-patient programs can help successfully meet patients' needs while addressing the unique challenges faced by smaller and emerging companies.
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Brand Stewardship: Best Practices for Maintaining Creative Integrity and Client Services
Date Posted: 03/29/2010
Size: 8.40MB
Length: 00:18:21
Thought Leaders: Tammy Fischer, President, GSW Worldwide in New York and Bruce Rooke, Chief Creative Officer, GSW Worldwide
Size: 8.40MB
Length: 00:18:21
Thought Leaders: Tammy Fischer, President, GSW Worldwide in New York and Bruce Rooke, Chief Creative Officer, GSW Worldwide
In this episode, Ms. Fischer and Mr. Rooke discuss best practices for brand stewardship and how to maintain creative integrity. They cover the issues as they relate to the client, the consumer, and the agency.
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Social Networking for Patient Recruitment for Clinical Trials
Date Posted: 03/18/2010
Size: 5.77MB
Length: 00:12:36
Thought Leader: Scott Connor, VP of Marketing, Acurian
Size: 5.77MB
Length: 00:12:36
Thought Leader: Scott Connor, VP of Marketing, Acurian
In this episode, Mr. Connor describes how social networking can be used as a powerful business tool for patient recruitment for clinical trials.
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Modernizing Incentive Compensation Plans
Date Posted: 03/16/2010
Size: 7.46MB
Length: 00:16:19
Thought Leader: Stephen M. Fox, Global Practice Leader, Sales Performance Center of Excellence, IMS Management Consulting
Size: 7.46MB
Length: 00:16:19
Thought Leader: Stephen M. Fox, Global Practice Leader, Sales Performance Center of Excellence, IMS Management Consulting
In this episode, Mr. Fox discusses incentive compensation plans in the pharmaceutical industry, why the incumbent plans aren't working, and how new solutions have emerged that improve the accuracy and efficiency of plans.
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Standards for Industry-Sponsored Studies and Journal Publication Planning
Date Posted: 03/12/2010
Size: 6.53MB
Length: 00:14:16
Thought Leaders: Bernadette Mansi, Scientific Communications Strategy Head, Cardiovascular, Metabolism and Ophthalmology, GlaxoSmithKline, and Dr. Trish Groves, Deputy Editor, British Medical Journal
Size: 6.53MB
Length: 00:14:16
Thought Leaders: Bernadette Mansi, Scientific Communications Strategy Head, Cardiovascular, Metabolism and Ophthalmology, GlaxoSmithKline, and Dr. Trish Groves, Deputy Editor, British Medical Journal
In this episode we cover the Medical Publishing Insights and Practices (MPIP) initiative, a relatively new development co-sponsored by Amgen, AstraZeneca, GlaxoSmithKline, Pfizer and the International Society for Medical Publication Professionals (ISMPP). Ms. Mansi and Dr. Groves discuss what MPIP is, who is behind the initiative, its goals and accomplishments, and how the pharmaceutical industry and journal editors and publishers are benefitting from collaboration on standards to elevate trust and transparency in publishing industry-sponsored studies. The latest undertaking is the creation of an Authors' Submission Toolkit: A Practical Guide to Getting Your Research Published, being rolled-out at the 6th Annual Meeting of ISMPP, April 19-21, Arlington, VA. To learn more and register, please visit http://www.ismpp.org.
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Tuesday, March 02, 2010
Commercial Compliance for Pharmaceutical and Medical Device Companies
Date Posted: 02/22/2010
Size: 5.62MB
Length: 00:12:17
Thought Leader: Daniel Garen, Chief Compliance Officer and Senior Counsel, Siemens Healthcare Sector, USA
Size: 5.62MB
Length: 00:12:17
Thought Leader: Daniel Garen, Chief Compliance Officer and Senior Counsel, Siemens Healthcare Sector, USA
In an exclusive interview with PharmaVOICE, Mr. Garen shares his expertise and insights on a variety of commercial compliance issues, including The Sunshine Act, Healthcare Reform, the Foreign Corrupt Practices Act (FCPA), and how companies can create a culture of compliance through proactivity. Mr. Garen is also the keynote speaker at the upcoming Marcus Evans' Commercial Compliance for Pharmaceutical and Medical Device Companies Conference, April 12-13, Washington, D.C. For more information about the conference, please go to: http://www.marcusevansch.com/commericalcompliance.
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Leveraging Digital Technology in Pharmaceutical Marketing: A New Agency Model
Date Posted: 01/19/2010
Size: 6.95MB
Length: 00:15:11
Thought Leaders: Kurt Holstein, Co-Founder and President, Rosetta, and Steven Michaelson, Founder and CEO, Wishbone
Thought Leaders: Kurt Holstein, Co-Founder and President, Rosetta, and Steven Michaelson, Founder and CEO, Wishbone
Mr. Holstein and Mr. Michaelson discuss the benefits and challenges of the new agency model that has emerged with the growth of digitally enabled communications.
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Tuesday, December 01, 2009
Performance-based Pricing in Patient Recruitment
Date Posted: 12/01/2009
Size: 14.4MB
Length: 00:14:04
Thought Leader: Richard Malcolm Ph.D., CEO, Acurian
Thought Leader: Richard Malcolm Ph.D., CEO, Acurian
Dr. Malcolm talks about risk sharing and performance-based pricing as a way for sponsors to get the best results for their patient recruiting budget.
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Friday, October 30, 2009
Podcast Overview
A 5-minute overview on Podcasts.
Learn how PharmaVOICE produces, promotes, and distributes podcasts, and how to maximize exposure for your thought leaders to the pharmaceutical industry.
Thursday, October 01, 2009
The Evolution of the E-Patient
Date: 10/01/2009
Length: 00:20:13
Size: 9.25MB
Thought Leader: Bonnie Brescia, Founding Principal, BBK Worldwide
Ms. Brescia provides an overview of the e-patient, how this special patient population can be leveraged for clinical trial participation, and how social media are impacting recruitment and clinical research.
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Tuesday, September 01, 2009
Return On Investment in Patient Recruitment
Date: 09/01/2009
Length: 00:22:47
Size: 10.4MB
Thought Leader: Richard Malcolm Ph.D., CEO, Acurian
Dr. Malcolm talks about planning and measuring return on investment in patient recruitment today, as well as what the future holds in this area.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Commercial Operations Outsourcing: A Leading-edge Response to the Financial Storm Affecting the Life-sciences Industry
Date: 08/01/2009
Length: 00:17:26
Size: 12.31MB
Thought Leaders: Jassi Chadha, Head of Analytics Practice, Cognizant, Patrick Brundage, Practice Leader, Life Sciences Analytics, Cognizant, and Nagaraja Srivatsan, VP and Head of Life Sciences, North America, Cognizant
In this special PharmaVOICE 100 podcast, our thought leaders discuss the current state of the life-sciences industry, the changes it is experiencing now, and what the industry will look like in the next decade.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157
The Digital Wave – Delivering Education and Services to Healthcare Providers
Date: 08/01/2009
Length: 00:11:50
Size: 5.41MB
Thought Leader: Donato Tramuto, CEO and Vice Chairman, Physicians Interactive
In this special PharmaVOICE 100 podcast, Mr. Tramuto discusses digital technologies that educate and provide important services to healthcare providers to improve communication and help deliver better patient outcomes.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157
The State of Women in Healthcare
Date: 08/01/2009
Length: 00:16:53
Size: 7.75MB
Thought Leader: Laurie P. Cooke, R.Ph., CEO, Healthcare Businesswomen's Association (HBA)
In this special PharmaVOICE 100 podcast, Ms. Cooke outlines the current state of women in healthcare, discusses the importance of mentoring, and shares her views on volunteerism. This episode also provides an overview of the HBA and its upcoming Annual Leadership Conference — Limitless Leadership: Bridging Today, Tomorrow, and Beyond — in November 2009.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157
Tuesday, June 09, 2009
Science is Greater than the Economy
Date: 05/29/2009
Length: 00:11:46
Size: 5.38MB
Thought Leaders: Lawrence Reiter, Ph.D., Director of Global Affairs, Criterium Inc.
Dr. Reiter discusses why it’s important to maintain R&D spending during fiscally challenging times, the pros and cons of a global R&D plan, how to do more with less, what technology brings to the table, and other critical factors to improve the development process.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157
Length: 00:11:46
Size: 5.38MB
Thought Leaders: Lawrence Reiter, Ph.D., Director of Global Affairs, Criterium Inc.
Dr. Reiter discusses why it’s important to maintain R&D spending during fiscally challenging times, the pros and cons of a global R&D plan, how to do more with less, what technology brings to the table, and other critical factors to improve the development process.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157
Charting a New Course by Catalyzing Transformation
Date: 05/28/2009
Length: 00:14:56
Size: 6.84MB
Thought Leaders: Adrian McKemey, Ph.D. Managing Director, Quintiles Consulting
Michael Arlotto, Ph.D., Senior Vice President, Quintiles Corporate Development.
In episode three, of a three-part series, “Surviving to Thriving in Stormy Weather,” our thought leaders discuss declining R & D productivity combined with increasing development costs. They offer insights and solutions to maximizing efficiencies and effecting change within R & D organizations in the biopharma industry.
Play Podcast
Download Related Whitepaper
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157
Length: 00:14:56
Size: 6.84MB
Thought Leaders: Adrian McKemey, Ph.D. Managing Director, Quintiles Consulting
Michael Arlotto, Ph.D., Senior Vice President, Quintiles Corporate Development.
In episode three, of a three-part series, “Surviving to Thriving in Stormy Weather,” our thought leaders discuss declining R & D productivity combined with increasing development costs. They offer insights and solutions to maximizing efficiencies and effecting change within R & D organizations in the biopharma industry.
Play Podcast
Download Related Whitepaper
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157
How to Connect Patients and Physicians Around Your Brand
Date: 05/27/2009
Length: 00:17:57
Size: 8.22MB
Thought Leaders: Michael Ball, Ph.D., VP of Marketing, InfoMedics
Paul LeVine, VP of Analytical Services, InfoMedics
In this episode, Dr. Ball and Mr. LeVine discuss the importance of patient feedback – how to obtain it and how it can be used to better connect brands with patients and physicians in a practice setting.
Play Podcast
Download Related Whitepaper
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157
Length: 00:17:57
Size: 8.22MB
Thought Leaders: Michael Ball, Ph.D., VP of Marketing, InfoMedics
Paul LeVine, VP of Analytical Services, InfoMedics
In this episode, Dr. Ball and Mr. LeVine discuss the importance of patient feedback – how to obtain it and how it can be used to better connect brands with patients and physicians in a practice setting.
Play Podcast
Download Related Whitepaper
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157
Connecting through Electronic Health Records
Date: 05/26/2009
Length: 00:14:41
Size: 6.72MB
Thought Leaders: Landen Bain, Liaison to Healthcare, CDISC
Dave Iberson-Hurst, VP of Technical Strategy, CDISC
In this episode, Mr. Bain and Mr. Iberson-Hurst discuss CDISC’s efforts in instituting standards for Electronic Health Records and RFD - Retrieve Form for Data Capture. They also cover where the organization’s efforts will be applied in the future.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157
Length: 00:14:41
Size: 6.72MB
Thought Leaders: Landen Bain, Liaison to Healthcare, CDISC
Dave Iberson-Hurst, VP of Technical Strategy, CDISC
In this episode, Mr. Bain and Mr. Iberson-Hurst discuss CDISC’s efforts in instituting standards for Electronic Health Records and RFD - Retrieve Form for Data Capture. They also cover where the organization’s efforts will be applied in the future.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157
Making Headway in Shifting Winds by Maximizing Value
Date: 5/01/2009
Length: 00:19:08
Size: 8.76MB
Thought Leaders: James Featherstone, Ph.D., VP of Product Development and Commercialization for the EU, Quintiles Consulting, Bruce E. Johnson, Ph.D., Senior Research Director, Eidetics, a division of Quintiles Consulting, and Heidi Hunter, Global VP, Business Development, Quintiles
In episode two, of a three-part series, "Surviving to Thriving in Stormy Weather," our thought leaders discuss new commercialization processes as healthcare moves towards personalized medicine. They also cover how to assess market potential for personalized therapies, post-launch sales strategies for niche drugs, and finally, meeting the needs of global and regional markets for these types of therapies.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157
Length: 00:19:08
Size: 8.76MB
Thought Leaders: James Featherstone, Ph.D., VP of Product Development and Commercialization for the EU, Quintiles Consulting, Bruce E. Johnson, Ph.D., Senior Research Director, Eidetics, a division of Quintiles Consulting, and Heidi Hunter, Global VP, Business Development, Quintiles
In episode two, of a three-part series, "Surviving to Thriving in Stormy Weather," our thought leaders discuss new commercialization processes as healthcare moves towards personalized medicine. They also cover how to assess market potential for personalized therapies, post-launch sales strategies for niche drugs, and finally, meeting the needs of global and regional markets for these types of therapies.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157
Thursday, April 30, 2009
Better Standards and Metrics for CROs and Sponsors
Date:4/08/2009
Length: 00:14:29
Size: 6.63MB
Thought Leaders:
Gregg Dearhammer, President, i3 Statprobe
Karen Goss, Global Director, Pharmacovigilance, i3 Drug Safety
In this episode, Mr. Dearhammer and Ms. Goss discuss the need for metrics and standards for clinical trials management and the impact of the Metrics Champion Consortium (MCC) on CROs and sponsors.
Play podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157
Length: 00:14:29
Size: 6.63MB
Thought Leaders:
Gregg Dearhammer, President, i3 Statprobe
Karen Goss, Global Director, Pharmacovigilance, i3 Drug Safety
In this episode, Mr. Dearhammer and Ms. Goss discuss the need for metrics and standards for clinical trials management and the impact of the Metrics Champion Consortium (MCC) on CROs and sponsors.
Play podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157
Thursday, April 02, 2009
Setting Sail for Success by Optimizing Productivity
Date:4/01/2009
Length: 00:14:31
Size: 6.64MB
Thought Leaders: Michael Hagan, Principal Consultant, Quintiles Consulting and James C. Kirk, VP and Practice Leader, Eidetics, Quintiles Consulting
In episode one, of a three-part series, “Surviving to Thriving in Stormy Weather,” Mr. Hagan and Mr. Kirk discuss market pressures and how economic turmoil in the biopharma industry can be overcome by using process optimization.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157
Length: 00:14:31
Size: 6.64MB
Thought Leaders: Michael Hagan, Principal Consultant, Quintiles Consulting and James C. Kirk, VP and Practice Leader, Eidetics, Quintiles Consulting
In episode one, of a three-part series, “Surviving to Thriving in Stormy Weather,” Mr. Hagan and Mr. Kirk discuss market pressures and how economic turmoil in the biopharma industry can be overcome by using process optimization.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157
Thursday, March 12, 2009
Overcoming Global Marketing and Regulatory Challenges
Date:3/02/2009
Length: 00:012:37
Size: 5.77MB
Thought Leaders: John Doyle Dr.P.H., Managing Director and Practice Leader, Market Access, Quintiles Consulting, and Geoff Garabedian, Managing Director and Practice Leader, Regulatory, Quintiles Consulting
In this episode, Dr. Doyle outlines cost-based evaluation and market-access strategies based on comparative effectiveness and safety research. Then Mr. Garabedian talks about the impact of regulatory globalization, and finally, there is a discussion covering the latest pharmaceutical initiatives from the European Commission, and how these will impact the global healthcare industry.
Play P0dcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157
Length: 00:012:37
Size: 5.77MB
Thought Leaders: John Doyle Dr.P.H., Managing Director and Practice Leader, Market Access, Quintiles Consulting, and Geoff Garabedian, Managing Director and Practice Leader, Regulatory, Quintiles Consulting
In this episode, Dr. Doyle outlines cost-based evaluation and market-access strategies based on comparative effectiveness and safety research. Then Mr. Garabedian talks about the impact of regulatory globalization, and finally, there is a discussion covering the latest pharmaceutical initiatives from the European Commission, and how these will impact the global healthcare industry.
Play P0dcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157
Global Clinical Trials Outsourcing: New Tips and Trends
Date:3/02/2009
Length: 00:012:25
Size: 5.68MB
Thought Leader: Patrick Durbin, VP, Fisher Clinical Services (a division of Thermo Fisher Scientific)
In this episode, Mr. Durbin offers some best practices for developing a strategic partnership with outsourcing providers, discusses some of the biggest challenges and missteps in global clinical trials outsourcing, covers emerging opportunities at the global level, and lists some of the most important emerging trends in this arena.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157
Length: 00:012:25
Size: 5.68MB
Thought Leader: Patrick Durbin, VP, Fisher Clinical Services (a division of Thermo Fisher Scientific)
In this episode, Mr. Durbin offers some best practices for developing a strategic partnership with outsourcing providers, discusses some of the biggest challenges and missteps in global clinical trials outsourcing, covers emerging opportunities at the global level, and lists some of the most important emerging trends in this arena.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157
Driving Sales Force Effectiveness in Turbulent Times
Date:2/23/2009
Length: 00:011:51
Size: 5.42MB
Thought Leader: Brett Knowles, Founder, Performance Measurement and Management
In this episode, Mr. Knowles discusses an actionable approach to boosting sales force performance, and how it has delivered results for Pharmaceutical companies in today's challenging environment.
Free Whitepaper Paper for download: Five Steps to Pharma Sales Force Effectiveness Click Here
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157
Length: 00:011:51
Size: 5.42MB
Thought Leader: Brett Knowles, Founder, Performance Measurement and Management
In this episode, Mr. Knowles discusses an actionable approach to boosting sales force performance, and how it has delivered results for Pharmaceutical companies in today's challenging environment.
Free Whitepaper Paper for download: Five Steps to Pharma Sales Force Effectiveness Click Here
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157
Pharmaceutical Forecasting Insights: The Process, Hurdles, and Important Trends
Date:1/30/2009
Length: 00:013:28
Size: 6.16MB
Thought Leader: Todd Johnson, Director of Forecasting, MattsonJack
In this episode, we discuss the importance and benefits of having an effective forecasting process, hurdles to implementation, available tools, and trends in the forecasting arena, particularly oncology forecasting. MattsonJack is holding a live workshop on forecasting in Scottsdale, AZ March 19-20. The workshop offers best practices, real-world tips and expert advice. To learn more about this important event Click Here.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157
Length: 00:013:28
Size: 6.16MB
Thought Leader: Todd Johnson, Director of Forecasting, MattsonJack
In this episode, we discuss the importance and benefits of having an effective forecasting process, hurdles to implementation, available tools, and trends in the forecasting arena, particularly oncology forecasting. MattsonJack is holding a live workshop on forecasting in Scottsdale, AZ March 19-20. The workshop offers best practices, real-world tips and expert advice. To learn more about this important event Click Here.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157
John Crowley’s Personal Crusade
Date:12/30/2008
Length: 00:07:18
Size: 3.34MB
Thought Leader: John Crowley, President and CEO, Amicus Therapeutics
In this episode, Mr. Crowley shares his personal journey to find viable treatements for Pompe disease, a condition which two of his children are afflicted. His amazing story is also showcased in the January issue of PharmaVOICE.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157
Length: 00:07:18
Size: 3.34MB
Thought Leader: John Crowley, President and CEO, Amicus Therapeutics
In this episode, Mr. Crowley shares his personal journey to find viable treatements for Pompe disease, a condition which two of his children are afflicted. His amazing story is also showcased in the January issue of PharmaVOICE.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157
Understanding the New PhRMA Code for Medically Relevant Items
Date:12/30/2008
Length: 00:13:00
Size: 5.95MB
Thought Leader: David Ganz, Managing Director, Total Health Rewards
In this episode, Mr. Ganz discusses the new PhRMA code as it relates to medically relevant items (MRIs) and how companies can stay compliant with this new guideline.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157
Length: 00:13:00
Size: 5.95MB
Thought Leader: David Ganz, Managing Director, Total Health Rewards
In this episode, Mr. Ganz discusses the new PhRMA code as it relates to medically relevant items (MRIs) and how companies can stay compliant with this new guideline.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157
Monday, December 15, 2008
Critical Care Opportunities in a Global Arena
Date:12/15/2008
Length: 00:12:05
Size: 5.50MB
Thought Leader: Clive Meanwell, M.D., PhD., Chairman and CEO, The Medicines Company
In this episode we talk about moving from a US focused to a globally focused company. We discuss several factors impacting the global pharmaceutical and healthcare market, and how outcomes research will be used in the future in the US and ex-US
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157 .
Length: 00:12:05
Size: 5.50MB
Thought Leader: Clive Meanwell, M.D., PhD., Chairman and CEO, The Medicines Company
In this episode we talk about moving from a US focused to a globally focused company. We discuss several factors impacting the global pharmaceutical and healthcare market, and how outcomes research will be used in the future in the US and ex-US
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157 .
Thursday, November 20, 2008
Demystifying Social Media — It's Not About Controlling the Message
Date:11/19/2008
Length: 00:11:56
Size: 5.46MB
Thought Leader: Ken Ribotsky, President and CEO, Core-Create
In this episode, Mr. Ribotsky discusses the relatively new web phenomenon called Social Media – what it is and how it can be used for improving brand messaging and communications.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157 .
Length: 00:11:56
Size: 5.46MB
Thought Leader: Ken Ribotsky, President and CEO, Core-Create
In this episode, Mr. Ribotsky discusses the relatively new web phenomenon called Social Media – what it is and how it can be used for improving brand messaging and communications.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157 .
Achieve Optimal Messaging for Your Inline Brand
Date:11/19/2008
Length: 00:16:21
Size: 7.48MB
Thought Leader: Ian McKinnon Ph.D., Senior Vice President, TNS Healthcare
In this episode, Dr. McKinnon discusses how brand teams can optimize their messages, evaluate their messengers (sales reps), and minimize the damage from competing messages in their market space.
Play Podcast
Download Related Presentation
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157 .
Length: 00:16:21
Size: 7.48MB
Thought Leader: Ian McKinnon Ph.D., Senior Vice President, TNS Healthcare
In this episode, Dr. McKinnon discusses how brand teams can optimize their messages, evaluate their messengers (sales reps), and minimize the damage from competing messages in their market space.
Play Podcast
Download Related Presentation
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157 .
The Benefits and Challenges of Creating Personalized Brand Dialogue Between Physicians and Patients
Date:11/19/2008
Length: 00:17:28
Size: 8.00MB
Thought Leaders: Paul LeVine, VP Analytical Services, InfoMedics and Dr. Stanley Wulf, Chief Medical Officer, InfoMedics
In this episode, Mr. LeVine and Dr. Wulf discuss ways to improve the dialog between physicians and patients using personalized data and communication tools in an effort to increase patient retention and health outcomes.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157 .
Length: 00:17:28
Size: 8.00MB
Thought Leaders: Paul LeVine, VP Analytical Services, InfoMedics and Dr. Stanley Wulf, Chief Medical Officer, InfoMedics
In this episode, Mr. LeVine and Dr. Wulf discuss ways to improve the dialog between physicians and patients using personalized data and communication tools in an effort to increase patient retention and health outcomes.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157 .
Procuring and Managing Clinical Staffing Resources
Date:11/19/2008
Length: 00:15:03
Size: 6.89MB
Thought Leader: Stephen Cottrell, Executive V.P. of Operations and Business Development, inVentiv Clinical Solutions
In this episode, Mr. Cottrell outlines many of the challenges in procuring and managing clinical staffing resources, and offers advice on how to overcome them.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157 .
Length: 00:15:03
Size: 6.89MB
Thought Leader: Stephen Cottrell, Executive V.P. of Operations and Business Development, inVentiv Clinical Solutions
In this episode, Mr. Cottrell outlines many of the challenges in procuring and managing clinical staffing resources, and offers advice on how to overcome them.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157 .
Ensuring Launch Success: Payer and Prescriber Considerations in
Thought Leader: Sarah Rickwood, Senior Principal, IMS
Play Podcast
Link to Related Videocast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157 .
Play Podcast
Link to Related Videocast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157 .
Fresh Approaches to Launch Success
Thought Leader: Robert Harold, Senior Principal, IMS
Play Podcast
Link to Related Videocast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157 .
Play Podcast
Link to Related Videocast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157 .
Winning in the Dynamic Market: Novel Approaches
Thought Leader: Lisa Morris, Global APLD Services, IMS
Play Podcast
Link to Related Videocast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157 .
Play Podcast
Link to Related Videocast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157 .
The Dynamic Market: Why It's the Most Important Area of Focus for Your Brand
Thought Leader: Robert Harold, Senior Principal, IMS
Play Podcast
Link to Related Videocast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157 .
Play Podcast
Link to Related Videocast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157 .
Changing the Game: New Opportunities in the Dynamic Market
Thought Leader: Lisa Morris, Global APLD Services, IMS
Play Podcast
Link to Related Videocast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157 .
Play Podcast
Link to Related Videocast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157 .
A Dual-Degree MSPharm/MBA Online Program Update
Date:10/17/2008
Length: 00:07:52
Size: 3.60MB
Program Representative: David B. Brushwood, R.Ph., J.D., Professor of Pharmaceutical Outcomes and Policy, University of Florida
In this episode, Professor Brushwood provides an update on a new online dual-degree program: a Master of Science in Pharmacy degree from the University of Florida and a Master of Business Administration from Stetson University. He discusses the benefits of the dynamic dual-degree, the program structure, the advantages of an online program, and admission requirements. Current registration period ends after November 1, 2008.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157 .
Length: 00:07:52
Size: 3.60MB
Program Representative: David B. Brushwood, R.Ph., J.D., Professor of Pharmaceutical Outcomes and Policy, University of Florida
In this episode, Professor Brushwood provides an update on a new online dual-degree program: a Master of Science in Pharmacy degree from the University of Florida and a Master of Business Administration from Stetson University. He discusses the benefits of the dynamic dual-degree, the program structure, the advantages of an online program, and admission requirements. Current registration period ends after November 1, 2008.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157 .
Monday, September 29, 2008
eClinical Moves into the Mainstream
Date:9/11/2008
Length: 00:13:28
Size: 6.17MB
Thought Leader: Stacey Arrambide, VP, Statistics and Data Management, inVentiv Clinical Solutions
In this episode, Stacey Arrambide shares her insights about the eClinical arena -- how it has evolved and what the benefits are, particularly regarding cost savings.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157 .
Length: 00:13:28
Size: 6.17MB
Thought Leader: Stacey Arrambide, VP, Statistics and Data Management, inVentiv Clinical Solutions
In this episode, Stacey Arrambide shares her insights about the eClinical arena -- how it has evolved and what the benefits are, particularly regarding cost savings.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157 .
Fighting Back: Technology Solutions to the Counterfeit Drug Problem
Date: 9/22/2008
Length: 00:15:56
Size: 7.29MB
Thought Leader: MaryAnn Hegedus, Business Development Manager, Colorcon
In this episode, Ms. Hegedus discusses the implications of the counterfeit drug market, and offers insights on how companies can use authentication technologies to protect their revenue, enable security throughout the entire supply chain at the dosage level, and improve consumer confidence.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157 .
Length: 00:15:56
Size: 7.29MB
Thought Leader: MaryAnn Hegedus, Business Development Manager, Colorcon
In this episode, Ms. Hegedus discusses the implications of the counterfeit drug market, and offers insights on how companies can use authentication technologies to protect their revenue, enable security throughout the entire supply chain at the dosage level, and improve consumer confidence.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157 .
The Pharma-Physician-Patient Connection: Working Together to Improve Treatment Outcomes
Date: 9/8/2008
Length: 00:14.49
Size: 6.78MB
Thought Leaders:
Dr. Stanley Wulf, Chief Medical Officer, InfoMedics
Ray Bullman, Executive VP of NCPIE (National Council on Patient Information and Education)
In this episode, our thought leaders share insights on improving treatment outcomes through patient adherence programs, including best practices and a look into the future of adherence programs.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Length: 00:14.49
Size: 6.78MB
Thought Leaders:
Dr. Stanley Wulf, Chief Medical Officer, InfoMedics
Ray Bullman, Executive VP of NCPIE (National Council on Patient Information and Education)
In this episode, our thought leaders share insights on improving treatment outcomes through patient adherence programs, including best practices and a look into the future of adherence programs.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Thursday, September 11, 2008
Molecular Design and the Critical Path Problem
Date:9/08/2008
Length: 00:16:35
Size: 7.59MB
Thought Leader: Stephen Byrn, Ph. D., Charles B. Jordan Professor of Medicinal Chemistry and Head of the Department of Industrial and Physical Pharmacy, Purdue University; and Head of the Aptuit Scientific Advisory Board
In this episode, Dr. Byrn speaks about the critical path problem in drug development and how a designed molecular delivery system can improve the drug development process.
Play Podcast
Download free related whitepaper
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Length: 00:16:35
Size: 7.59MB
Thought Leader: Stephen Byrn, Ph. D., Charles B. Jordan Professor of Medicinal Chemistry and Head of the Department of Industrial and Physical Pharmacy, Purdue University; and Head of the Aptuit Scientific Advisory Board
In this episode, Dr. Byrn speaks about the critical path problem in drug development and how a designed molecular delivery system can improve the drug development process.
Play Podcast
Download free related whitepaper
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Thursday, July 31, 2008
E-Clinical: Driving Efficiencies and Reducing Costs for Drug Development
Date:7/30/2008
Length: 00:16:44
Size: 7.66MB
Thought Leader: Chris Porter, Cofounder and Chief Operating Officer, Clinipace
In this episode, Taren Grom, Editor, PharmaVOICE, speaks with 2008 PharmaVOICE 100 honoree Chris Porter about the need for a better clinical model, one driven by affordable technology and software solutions, as well as best practices to improve clinical research processes.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Length: 00:16:44
Size: 7.66MB
Thought Leader: Chris Porter, Cofounder and Chief Operating Officer, Clinipace
In this episode, Taren Grom, Editor, PharmaVOICE, speaks with 2008 PharmaVOICE 100 honoree Chris Porter about the need for a better clinical model, one driven by affordable technology and software solutions, as well as best practices to improve clinical research processes.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Insights on Developing a Career Path in the New Era of the Life Sciences
Date:7/30/2008
Length: 00:15:08
Size: 6.93MB
Thought Leader: Howard Weisman, CoFounder, CEO, and Chairman, EKR Therapeutics Inc.
In this episode, Taren Grom, Editor, PharmaVOICE, speaks with Mr. Weisman, a 2008 PharmaVOICE 100 honoree, about how to maximize career opportunities in the pharmaceutical industry and how the career paths are changing.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Length: 00:15:08
Size: 6.93MB
Thought Leader: Howard Weisman, CoFounder, CEO, and Chairman, EKR Therapeutics Inc.
In this episode, Taren Grom, Editor, PharmaVOICE, speaks with Mr. Weisman, a 2008 PharmaVOICE 100 honoree, about how to maximize career opportunities in the pharmaceutical industry and how the career paths are changing.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Friday, July 18, 2008
Mobile Devices: Connecting Physicians and Pharma
Date:7/15/2008
Length: 00:10:38
Size: 4.87MB
Thought Leader: Sandeep Shah, President and Founder, Skyscape
In this episode, Taren Grom, Editor, PharmaVOICE, speaks with Mr. Shah about the importance of wireless mobile devices to physicians and how pharmaceutical companies can leverage this platform for physician communications.Free Report: Effect of PDA-Based Information on Treatment Decisions
Play Podcast
Download Related Free Report
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Length: 00:10:38
Size: 4.87MB
Thought Leader: Sandeep Shah, President and Founder, Skyscape
In this episode, Taren Grom, Editor, PharmaVOICE, speaks with Mr. Shah about the importance of wireless mobile devices to physicians and how pharmaceutical companies can leverage this platform for physician communications.Free Report: Effect of PDA-Based Information on Treatment Decisions
Play Podcast
Download Related Free Report
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Patient Journey Marketing™ and the Power of Video
Date:7/8/2008
Length: 00:17:52
Size: 8.32MB
Thought Leader: Liz Kay, VP, Account Services, Healthcare Practice, Cramer
In this episode, Liz Kay discusses the use of online video as an effective and interactive medium for patient communications.Whitepaper: How Patient Journey Marketing™ delivers more value to your customers and your bottom line
Play Podcast
Download Related White Paper
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Length: 00:17:52
Size: 8.32MB
Thought Leader: Liz Kay, VP, Account Services, Healthcare Practice, Cramer
In this episode, Liz Kay discusses the use of online video as an effective and interactive medium for patient communications.Whitepaper: How Patient Journey Marketing™ delivers more value to your customers and your bottom line
Play Podcast
Download Related White Paper
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Improving Clinical Operations at AstraZeneca
Date:6/27/2008
Length: 00:16:09
Size: 7.39MB
Thought Leader: Karen Gotting-Smith, Ph.D. VP, Business Performance and Continuous Improvement, AstraZeneca Pharmaceuticals
Taren Grom, CoFounder and Editor-in-Chief of PharmaVOICE talks with Dr. Gotting-Smith about current market factors driving change in clinical operations, outsourcing considerations, new technologies and advances in data management.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Length: 00:16:09
Size: 7.39MB
Thought Leader: Karen Gotting-Smith, Ph.D. VP, Business Performance and Continuous Improvement, AstraZeneca Pharmaceuticals
Taren Grom, CoFounder and Editor-in-Chief of PharmaVOICE talks with Dr. Gotting-Smith about current market factors driving change in clinical operations, outsourcing considerations, new technologies and advances in data management.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Subscribe to:
Posts (Atom)